Wolverine Trading’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.6M | Buy |
62,800
+21,700
| +53% | +$3.85M | 0.01% | 813 |
|
|
2025
Q2 | $7.14M | Buy |
41,100
+3,200
| +8% | +$482K | 0.01% | 842 |
|
|
2025
Q1 | $5.05M | Sell |
37,900
-72,700
| -66% | -$9.57M | 0.01% | 986 |
|
|
2024
Q4 | $13.9M | Buy |
110,600
+6,400
| +6% | +$952K | 0.01% | 631 |
|
|
2024
Q3 | $17M | Buy |
104,200
+37,400
| +56% | +$5.66M | 0.02% | 492 |
|
|
2024
Q2 | $8.89M | Sell |
66,800
-10,300
| -13% | -$1.24M | 0.01% | 684 |
|
|
2024
Q1 | $8.1M | Sell |
77,100
-4,300
| -5% | -$386K | 0.01% | 742 |
|
|
2023
Q4 | $6.15M | Buy |
81,400
+1,700
| +2% | +$108K | 0.01% | 962 |
|
|
2023
Q3 | $5.25M | Buy |
+79,700
| New | +$5.96M | 0.01% | 976 |
|
|
2023
Q1 | – | Sell |
-72,200
| Closed | -$3.52M | – | 4938 |
|
|
2022
Q4 | $3.52M | Buy |
72,200
+37,800
| +110% | +$1.75M | 0.01% | 1068 |
|
|
2022
Q3 | $1.82M | Sell |
34,400
-19,400
| -36% | -$1.15M | ﹤0.01% | 1478 |
|
|
2022
Q2 | $3.04M | Buy |
53,800
+1,500
| +3% | +$104K | 0.01% | 1073 |
|
|
2022
Q1 | $4.55M | Sell |
52,300
-24,100
| -32% | -$1.98M | 0.01% | 1130 |
|
|
2021
Q4 | $6.26M | Sell |
76,400
-25,900
| -25% | -$1.89M | 0.01% | 1000 |
|
|
2021
Q3 | $7.02M | Buy |
102,300
+25,100
| +33% | +$1.78M | 0.01% | 1049 |
|
|
2021
Q2 | $5.1M | Buy |
+77,200
| New | +$4.79M | 0.01% | 1124 |
|
|
2021
Q1 | – | Sell |
-31,500
| Closed | -$1.25M | – | 6393 |
|
|
2020
Q4 | $1.25M | Sell |
31,500
-12,600
| -29% | -$407K | ﹤0.01% | 2151 |
|
|
2020
Q3 | $1.04M | Buy |
44,100
+7,900
| +22% | +$202K | ﹤0.01% | 2039 |
|
|
2020
Q2 | $659K | Sell |
36,200
-4,900
| -12% | -$96.5K | ﹤0.01% | 2435 |
|
|
2020
Q1 | $655K | Sell |
41,100
-22,900
| -36% | -$657K | ﹤0.01% | 2366 |
|
|
2019
Q4 | $2.42M | Sell |
64,000
-48,200
| -43% | -$1.44M | 0.01% | 1682 |
|
|
2019
Q3 | $2.45M | Buy |
112,200
+25,700
| +30% | +$548K | 0.01% | 1303 |
|
|
2019
Q2 | $1.79M | Buy |
86,500
+9,500
| +12% | +$219K | 0.01% | 1593 |
|
|
2019
Q1 | $2.22M | Sell |
77,000
-59,500
| -44% | -$1.47M | 0.01% | 1455 |
|
|
2018
Q4 | $2.36M | Sell |
136,500
-16,200
| -11% | -$392K | 0.01% | 1291 |
|
|
2018
Q3 | $4.35M | Sell |
152,700
-26,100
| -15% | -$862K | 0.01% | 1070 |
|
|
2018
Q2 | $4.34M | Hold |
178,800
| – | – | 0.01% | 987 |
|
|
2018
Q1 | $4.34M | Sell |
178,800
-100,600
| -36% | -$2M | 0.01% | 987 |
|
|
2017
Q4 | $4.24M | Sell |
279,400
-4,300
| -2% | -$60.5K | 0.02% | 978 |
|
|
2017
Q3 | $4.66M | Buy |
+283,700
| New | +$4.81M | 0.02% | 808 |
|
|
2017
Q2 | – | Sell |
-105,900
| Closed | -$1.93M | – | 4957 |
|
|
2017
Q1 | $1.93M | Sell |
105,900
-72,200
| -41% | -$1.34M | 0.01% | 1221 |
|
|
2016
Q4 | $2.64M | Buy |
178,100
+55,000
| +45% | +$987K | 0.01% | 1136 |
|
|
2016
Q3 | $2.71M | Buy |
123,100
+20,400
| +20% | +$531K | 0.01% | 1111 |
|
|
2016
Q2 | $2.84M | Buy |
+102,700
| New | +$3.03M | 0.02% | 897 |
|
Other funds holding THC
GCM
Wolverine Trading's THC Position: Q3 2025 in Review
Wolverine Trading reduced its Tenet Healthcare (THC) stake by 25% in Q3 2025, selling an estimated $194K and leaving 3,249 shares worth $654K. The position accounts for ﹤0.01% of the portfolio, ranked #3382.
Wolverine Trading first reported a position in THC in Q3 2016 and has held it in 24 quarters since. The position peaked at $2.73M in Q4 2019. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.
- Wolverine Trading held 3,249 shares of Tenet Healthcare worth $654K as of Q3 2025.
- Wolverine Trading sold 1,094 Tenet Healthcare shares in Q3 2025, an estimated $194K.
- Tenet Healthcare made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3382 holding.
- Wolverine Trading first reported a position in Tenet Healthcare in Q3 2016 and has held it in 24 quarters since.
- Wolverine Trading's Tenet Healthcare position peaked at $2.73M in Q4 2019.
- 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.